首页> 外文期刊>Nature Communications >Orthogonal ring-closing alkyne and olefin metathesis for the synthesis of small GTPase-targeting bicyclic peptides
【24h】

Orthogonal ring-closing alkyne and olefin metathesis for the synthesis of small GTPase-targeting bicyclic peptides

机译:正交闭环炔烃和烯烃复分解用于合成靶向GTPase的小双环肽

获取原文
           

摘要

Bicyclic peptides are promising scaffolds for the development of inhibitors of biological targets that proved intractable by typical small molecules. So far, access to bioactive bicyclic peptide architectures is limited due to a lack of appropriate orthogonal ring-closing reactions. Here, we report chemically orthogonal ring-closing olefin (RCM) and alkyne metathesis (RCAM), which enable an efficient chemo- and regioselective synthesis of complex bicyclic peptide scaffolds with variable macrocycle geometries. We also demonstrate that the formed alkyne macrocycle can be functionalized subsequently. The orthogonal RCM/RCAM system was successfully used to evolve a monocyclic peptide inhibitor of the small GTPase Rab8 into a bicyclic ligand. This modified peptide shows the highest affinity for an activated Rab GTPase that has been reported so far. The RCM/RCAM-based formation of bicyclic peptides provides novel opportunities for the design of bioactive scaffolds suitable for the modulation of challenging protein targets.
机译:双环肽是用于开发被典型的小分子证明难以治疗的生物靶标抑制剂的有前途的支架。到目前为止,由于缺乏适当的正交闭环反应,限制了对生物活性双环肽结构的访问。在这里,我们报告化学正交闭环烯烃(RCM)和炔烃复分解(RCAM),这使得能够有效地化学和区域选择性合成具有可变大环几何形状的复杂双环肽支架。我们还证明了随后形成的炔烃大环可以被官能化。正交RCM / RCAM系统已成功用于将小GTPase Rab8的单环肽抑制剂进化为双环配体。迄今为止,已报道该修饰的肽对活化的Rab GTP酶显示出最高的亲和力。基于RCM / RCAM的双环肽的形成为设计适于调节具有挑战性的蛋白质靶标的生物活性支架提供了新的机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号